Trials
Search / Trial NCT06425289

Macrohemodynamic Impact of Fluid Removal With Net Ultrafiltration in Patients With Continuous Renal Replacement Therapy

Launched by HOSPICES CIVILS DE LYON · May 21, 2024

Trial Information

Current as of February 19, 2025

Not yet recruiting

Keywords

Fluid Removal Hemodynamic Net Ultrafiltration Continuous Renal Replacement Therapy

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Acute kidney injury treated by continuous renal replacement therapy in ICU less than 7 days,
  • At least 1 organ failure during ICU in addition to AKI (mechanical ventilation or vasopressors administration\>12 hours),
  • Cumulative UF net less than 1000ml before inclusion,
  • Norepinephrine \< 0,5 µg/kg/min,
  • Absence of hypoperfusion signs,
  • Fluid overload defined as follows: fluid overload \> 5% of base weight (based on cumulative fluid balance or a weight gain) and/or peripheral edema (AKIKI edema scale \> 2).
  • Exclusion Criteria:
  • Chronic renal failure hemodialyzed before admission to the ICU,
  • Mechanical circulatory support (ECMO, LVAD),
  • Pregnant, child -bearing age or lactating women,
  • Stroke less than 30 days,
  • Intestinal ischemia less than 7 days documented non-operated,
  • Interventional study participation or exclusion period on going,
  • Guardianship, curatorship or safeguard of justice,
  • Absence of signature of free and informed consent by the patient and/or relative,
  • Patients not affiliated to a social security scheme or beneficiaries of a similar scheme
  • Absence of transpulmonary thermodilution monitoring

About Hospices Civils De Lyon

Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.

Locations

Bron, , France

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0